# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12065404).pn
Enveric and Aries recently announced a Licensing Agreement for patented topical product aimed at treating radiation dermatitis,...
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $...
https://www.greenmarketreport.com/mdma-therapy-gets-support-from-prominent-research-group-as-fda-weighs-action/ The paper noted...
-SEC Filing
Enveric Biosciences has been granted a U.S. patent for EB-002, enhancing protection for treatments targeting brain neurological...